5 completed, 2 unknown. 1 Phase 2, 1 Phase 3, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Completed 1 |
| Phase 3 | 1 | Completed 1 |
| Phase 4 | 1 | Unknown 1 |
Follow Thromboembolic Events: new trials by email Literature Review of Thromboembolic Events trials Research Report on Thromboembolic Events
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Tirofiban for Reduction of Thromboembolic Events in Endovascular Unruptured Aneurysm Repair Tirofiban, aspirin, clopidogrel - Unruptured Intracranial Aneurysm, Flow Diverter | Phase 2 / Phase 3 | Completed | Beijing Tiantan Hospital | 192 | 2024-03-04 | 2025-12-11 |
| Anticoagulant Therapy and 28-days Mortality in Critically Ill COVID-19 Patients Dose of Tinzaparin or Dalteparin - Covid-19, Thromboembolic Events | Completed | Karolinska Institutet | 166 | 2020-03-06 | 2020-06-22 | |
| Association of Genetic Variants With Risk of Stroke in Patients With Atrial Fibrillation Off-anticoagulation Thromboembolic Events | Unknown | Texas Cardiac Arrhythmia Research Foundation | 40 | 2019-10-01 | 2019-10-17 | |
| Lovenox 30 mg Twice Daily (BID) Versus 40 mg Once Daily (QD) Enoxaparin Sodium Injection 30 mg BID, Enoxaparin Sodium Injection 40 mg QD - Trauma, Surgery | Phase 4 | Unknown | Oregon Health and Science University | 606 | 2014-02-01 | 2024-04-03 |
| Management and Detection of Atrial Tachyarrhythmias in Patients Implanted With BIOTRONIK DX Systems Atrial Fibrillation, Tachycardia | Completed | Biotronik SE & Co. KG | 2054 | 2013-01-01 | 2018-09-25 | |
| Clinical Performance Evaluation of Pefakit® PiCT® UC In Vitro Diagnostic Medical Device Thromboembolic Events | Completed | dsm-firmenich Switzerland AG | 123 | 2012-04-01 | 2015-05-06 | |
| Frequency of Vascular Events With Short-term Thromboprophylaxis in Fast-track Hip and Knee-arthroplasty. Thromboembolic Events, Post-operative Bleeding | Completed | Copenhagen University Hospital, Rigshospitalet | 4924 | 2010-02-01 | 2021-01-27 |
Thromboembolism (7) · Atrial Fibrillation (1) · COVID-19 (1) · Heart Failure (1) · Hemorrhage (1) · Stroke (1) · Tachycardia (1) · Venous Thromboembolism (1) · Venous Thrombosis (1) · Wounds and Injuries (1)
Cardiovascular Diseases (7) · Embolism and Thrombosis (7) · Vascular Diseases (7) · Pathologic Processes (2) · Pathological Conditions, Signs and Symptoms (2) · Arrhythmias, Cardiac (1) · Brain Diseases (1) · Cardiac Conduction System Disease (1) · Central Nervous System Diseases (1) · Cerebrovascular Disorders (1) · Coronaviridae Infections (1) · Coronavirus Infections (1) · Heart Diseases (1) · Infections (1) · Lung Diseases (1)
Aspirin (1) · BID protein, human (1) · Clopidogrel (1) · Dalteparin (1) · Enoxaparin (1) · Tirofiban (1) · enoxaparin sodium (1)
Beijing Tiantan Hospital (1) · Biotronik SE & Co. KG (1) · Copenhagen University Hospital, Rigshospitalet (1) · Karolinska Institutet (1) · Oregon Health and Science University (1) · Texas Cardiac Arrhythmia Research Foundation (1) · dsm-firmenich Switzerland AG (1)
United States (3) · Germany (2) · China (1) · Denmark (1) · Sweden (1) · Switzerland (1)
Christoffer C Joergensen, MD (1) · Gerhard Hindricks, Prof. Dr. (1) · Henrik Kehlet, Professor (1) · Jing Jing (1) · Kjeld Soeballe, Professor (1) · Manuela K. Krause, MD (1) · Maria Cronhjort, PhD (1) · Martin A Schreiber, MD (1) · Rathbun Suman, MD (1) · Wolfgang Korte (1)